About Us

Social responsibility

Hansoh Pharma included in “Outstanding CSR Projects of Pharmaceutical Enterprises in China 2018”

2019.08.26 Size

Medicine is closely related to people's health, and the social responsibility of pharmaceutical enterprises in China has received much attention. On August 25, the 4th CSR Alliance Ceremony of Pharmaceutical Enterprises in China and the release ceremony of "Outstanding CSR Projects of Pharmaceutical Enterprises in China 2018" kicked off in Lianyungang. This release ceremony was an important part of the "(36th) China Pharmaceutical Industry Information Conference 2019", aiming to unite the forces of the industry, encourage and guide pharmaceutical enterprises to actively fulfill their corporate social responsibility and promote the healthy development of China's pharmaceutical industry. At the conference, Hansoh Pharma's “Practice green pharmaceuticals and accelerate transformation and upgrading” project was included in“ Outstanding CSR Projects of Pharmaceutical Enterprises in China 2018”.

As we know, Hansoh Pharma always insists on integrating social responsibility, technological innovation and high-quality production into its own and social development. Since the implementation of the “Practice green pharmaceuticals and accelerate transformation and upgrading” project, Hansoh Pharma has been actively exploring a new model of green production management, improving the organization and management system of energy conservation work, assessment, reward and punishment system and statistical monitoring system, effectively consolidating the management foundation of energy conservation and emission reduction, and implementing the green, environmental and low-carbon approach throughout the entire process of design, production and application to build itself into a green, responsible brand, while strictly abiding by and implementing the relevant national laws and regulations on energy conservation and emission reduction and energy consumption quota labeling.

According to the relevant principal of the company, Hansoh Pharma has carried out technological innovation and system optimization through the coordinated development of green production, achieving the lowest environmental impact, the highest resource and energy utilization rate, and the coordinated optimization of economic, ecological and social benefits. Such a project not only helps accelerate the adjustment of China's economic structure and transformation of its development mode, and also is an important measure to deal with global low-carbon competition as well as an important means to ensure China's energy and resource security.